Publications by authors named "Barbara Guerrera"

Claim this Profile
R
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study.
Luigi E Adinolfi, Salvatore Petta, Anna L Fracanzani, Riccardo Nevola, Carmine Coppola, Barbara Guerrera

Diabetes Obes Metab· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Presentation of a Rare Parasitic Infection with Fasciola hepatica: A Multidisciplinary Case Report.
Luca Rinaldi, Veronica Folliero, Luciano Restivo, Francesco Foglia, Gianluigi Franci, Barbara Guerrera

Am J Case Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antivirals.
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera

JGH Open· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study.
Luigi Elio Adinolfi, Salvatore Petta, Anna Ludovica Fracanzani, Carmine Coppola, Vincenzo Narciso, Barbara Guerrera

Atherosclerosis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience.
Luca Rinaldi, Maria Guarino, Alessandro Perrella, Pia Clara Pafundi, Giovanna Valente, Barbara Guerrera

Dig Dis Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV genotype-3h, a difficult-to-diagnose sub-genotype in the DAA era.
Carmine Minichini, Mario Starace, Stefania De Pascalis, Margherita Macera, Laura Occhiello, Barbara Guerrera

Antivir Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study.
Luca Rinaldi, Alessandro Perrella, Maria Guarino, Massimo De Luca, Guido Piai, Barbara Guerrera

J Transl Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress.
Rosa Zampino, Aldo Marrone, Luca Rinaldi, Barbara Guerrera, Riccardo Nevola

Infection· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
Luigi E Adinolfi, Riccardo Nevola, Barbara Guerrera, Giovanni D'Alterio, Aldo Marrone

J Gastroenterol Hepatol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.
Luca Rinaldi, Fabio Nascimbeni, Mauro Giordano, Chiara Masetti, Barbara Guerrera

World J Gastroenterol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study.
Giuseppe Ruggiero, Aldo Marrone, Ilaria Rainone, Adriana Boemio, Luigi Elio Adinolfi, Barbara Guerrera

Infez Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.
Cleo Study Group, Antonio Ascione, Luigi Elio Adinolfi, Pietro Amoroso, Angelo Andriulli, Barbara Guerrera

World J Hepatol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations.
Luigi Elio Adinolfi, Luca Rinaldi, Barbara Guerrera, Luciano Restivo, Aldo Marrone

Int J Mol Sci· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-oral interferon-free treatments: The end of hepatitis C virus story, the dream and the reality.
Luigi E Adinolfi, Barbara Guerrera

World J Hepatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.
Luigi Elio Adinolfi, Riccardo Nevola, Giacomo Lus, Luciano Restivo, Barbara Guerrera

World J Gastroenterol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.
Luigi E Adinolfi, Rosa Zampino, Luciano Restivo, Amedeo Lonardo, Barbara Guerrera

World J Gastroenterol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic HCV infection is a risk factor of ischemic stroke.
Luigi E Adinolfi, Luciano Restivo, Barbara Guerrera, Ausilio Sellitto, Antonella Ciervo

Atherosclerosis· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.
Rosa Zampino, Aldo Marrone, Luciano Restivo, Barbara Guerrera, Ausilia Sellitto

World J Hepatol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.
Luigi E Adinolfi, Luciano Restivo, Rosa Zampino, Barbara Guerrera, Amedeo Lonardo

Atherosclerosis· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic melanoma: an unusual presentation.
Ferdinando De Vita, Guido Giordano, Alessio Fabozzi, Barbara Guerrera, Teresa Fabozzi

Tumori· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis